HCA Healthcare (HCA) EBITDA Margin (2010 - 2026)

HCA Healthcare (HCA) has 17 years of EBITDA Margin data on file, last reported at 2.96% in Q1 2026.

• EBITDA Margin for Q1 2026 came in at 2.96%, up 532.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.9% (down 101.0% YoY), and the FY2025 annual result was 7.37%, up 17.0% from the prior year.
• EBITDA Margin climbed to 2.96% in Q1 2026 per HCA's latest filing, from 24.72% in the prior quarter.
• Over five years, EBITDA Margin peaked at 17.73% in Q4 2022 and troughed at 25.84% in Q4 2024.
• A 5-year average of 1.1% and a median of 8.46% in 2022 frame the typical range for EBITDA Margin.
• The sharpest annual moves came in 2024 and 2026: EBITDA Margin plunged 3697 bps in 2024, then jumped 532 bps in 2026.
• A 5-year view of EBITDA Margin shows it stood at 17.73% in 2022, then sank by 37 bps to 11.14% in 2023, then sank by 332 bps to 25.84% in 2024, then gained by 4 bps to 24.72% in 2025, then surged by 88 bps to 2.96% in 2026.
• Business Quant data shows HCA's EBITDA Margin at 2.96% in Q1 2026, 24.72% in Q4 2025, and 9.1% in Q3 2025.